Pages that link to "Item:Q2881036"
From MaRDI portal
The following pages link to Identifying therapeutic targets in a combined EGFR-TGF\(\beta\)R signalling cascade using a multiscale agent-based cancer model (Q2881036):
Displaying 6 items.
- Selecting optimal drug-intervention in a pathway involving receptor tyrosine kinases (RTKs) (Q272703) (← links)
- A 3D multiscale model to explore the role of EGFR overexpression in tumourigenesis (Q2002113) (← links)
- Mathematical modeling of the dimerization of EGFR and ErbB3 in lung adenocarcinoma (Q2088509) (← links)
- Targeting cellular DNA damage responses in cancer: an in vitro-calibrated agent-based model simulating monolayer and spheroid treatment responses to ATR-inhibiting drugs (Q2230682) (← links)
- Identification of crucial parameters in a mathematical multiscale model of glioblastoma growth (Q2262489) (← links)
- Mathematical modeling and analysis of ErbB3 and EGFR dimerization process for the gefitinib resistance (Q3121410) (← links)